HOME >> BIOLOGY >> NEWS
Cornell scientists link E. coli bacteria to Crohn's disease

ITHACA, N.Y. A team of Cornell University scientists from the College of Veterinary Medicine, Weill Cornell Medical College and the College of Agriculture and Life Sciences have discovered that a novel group of E. coli bacteria containing genes similar to those described in uropathogenic and avian pathogenic E. coli and enteropathogenic bacteria such as salmonella, cholera, bubonic plague is associated with intestinal inflammation in patients with Crohns disease in their research paper published July 12 by The ISME Journal: Multidisciplinary Journal of Microbial Ecology.

Crohns disease, an incurable inflammatory disorder of the intestine most commonly found in the lower part of the small intestine called the ileum affects 1-in-1,000 people in Europe and North America. Thus far, gut bacteria have long been suspected in playing a pivotal role in the development of Crohns disease, but the specific bacterial characteristics that drive the inflammatory response have remained elusive.

Researchers at Cornell examined possible causes for the disease in patients with Crohns restricted to the ileum and the colon versus healthy individuals.

Given that only about 20 percent of fecal bacteria can be cultured, our group adopted a broad culture-independent approach to target specific subgroups of bacteria for quantitative in situ analysis and culture based characterization, said Kenneth Simpson, professor of small animal medicine at the College of Veterinary Medicine. Our findings raise the possibility that a novel group of E. coli contains opportunistic pathogens that may be causally related to chronic intestinal inflammation in susceptible individuals. They suggest that an integrated approach that considers an individuals mucosa-associated flora in addition to disease phenotype and genotype may improve outcome.

The study found an increased level of E. coli bacteria in more inflamed areas of the small intestines instead of MAP, a bacterium related
'"/>

Contact: Sabina Lee
ssl37@cornell.edu
607-255-3024
Cornell University News Service
7-Aug-2007


Page: 1 2

Related biology news :

1. Weill Cornell team identifies potential new cancer drug target
2. Methodist, University of Houston, Cornell combine biomedical imaging expertise
3. Weill Cornell pharmacologist receives prestigious NIH MERIT Award
4. Cornell lab confirms deadly fish virus spreading to new species
5. NSF awards $3.3 million grant to Cornell to bolster the percentage of women faculty members
6. Cornell researchers find serious fish virus in Northeast for first time
7. Cornell finds natural selection in humans
8. Northeast Sun Grant Institute at Cornell spurs green revolution
9. Stem cell research at Weill Cornell, The Rockefeller University, and Sloan-Kettering
10. Cornell graduate student named 2005 AIBS Emerging Public Policy Leader
11. Weill Cornell team develops fast-acting anthrax vaccine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/28/2020)... and CAMBRIDGE, Mass. (PRWEB) , ... January 28, ... ... complex problems for life sciences companies and government agencies, announced that the firm ... hubs in the country. Tunnell’s Cambridge office will be in the Cambridge Innovation ...
(Date:1/27/2020)... ... 2020 , ... Cytonus Therapeutics Inc. today announced the appointment ... former senior management consultant at McKinsey & Company who holds three Harvard degrees. ... , “Chris Thorne has exceptional business acumen with a proven track record ...
(Date:1/24/2020)... ... January 24, 2020 , ... Worldwide Business with ... President Dr. Stanley Stanbridge and Vice President of Sales and Marketing Jeff Maier to ... Network as sponsored content on Sunday, Jan. 26, 2020 at 5:30 p.m. EST and ...
Breaking Biology News(10 mins):
(Date:1/27/2020)... ... January 27, 2020 , ... ... has secured financing from strategic investors led by Halma plc , a ... investors Sonion, TDF Ventures, GII LLC, and WSJ Joshua Fund. A representative from ...
(Date:1/23/2020)... ... January 22, 2020 , ... Ideal Implant CEO and President ... two recent North American investor forums specializing in medical advancements. New technology was ... Diagnostics Forum on November 21, 2019 in New York City, and the Aesthetic ...
(Date:1/22/2020)... ... 2020 , ... QCDx , a private biotech company that has developed ... announced the sale of the proprietary RareScope™ instrument to the Carole and Ray Neag ... cancer research. , “The RareScope can detect and isolate intact and live Circulating Tumor ...
(Date:1/8/2020)... ... 2020 , ... Anomet Products has introduced new ... in harsh environments inside or outside of the human body. , ... to achieve specific properties such as corrosion-resistance, biocompatibility, or operation at temperatures from ...
Breaking Biology Technology:
Cached News: